
...
By Shaun McAvoy
Contributing Sports Writer
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
For the first time since Game 5 of the 2024 World Series, New York Yankees ace Gerrit Cole took the mound to pitch one inning in spring training against the Boston Red Sox.
Cole gave up a bunt hit on the first pitch of his return, but bounced back and got out of the inning without giving up a run, despite giving up another hit to left field. The 33-year-old threw seven of his 10 pitches for strikes and had command over the strike zone.
The Yankees missed Cole last season after the Cy Young Award winner underwent Tommy John surgery in March, but were ecstatic to see him back on the mound again. The velocity was there for the right-handed veteran, with his fastest pitch touching 98.7 mph, and he looked sharp despite it being a short outing.
Read More on MLB

Though Cole has been ahead in his rehab, the target for the six-time All-Star's full return is still expected to be the middle of June at best. Despite Cole remaining on the injured list for now, his start against the Red Sox means so much for the Yankees moving forward.
With Cole back in the rotation, New York has a bona fide ace to spearhead its starting rotation. The Yankees boasted arguably the best offense in all of baseball, scoring the most runs and mashing the most home runs, and have brought back essentially the same starting lineup this season. In addition to boasting one of the best offenses in the MLB, the New York could also have one of the best starting rotations after Cole's return.
New York followed up a trip to the World Series in 2024 with a disappointing early exit against the Toronto Blue Jays in the ALDS last season, but with Cole fully healthy, the Yankees' aspirations are through the roof as the team focuses on returning to the World Series and securing a championship.
More MLB: Former Cubs Reliever Emerging As Intriguing Yankees Bullpen Option
View 0 Comments
Submit Correction
View Editorial & AI Guidelines